Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of $6.92 million. The enterprise value is $331,722.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 65.88 million shares outstanding. The number of shares has increased by 30.74% in one year.
| Current Share Class | 65.88M |
| Shares Outstanding | 65.88M |
| Shares Change (YoY) | +30.74% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 22.58% |
| Float | 46.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.21 |
| Forward PS | 9.25 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 2.97.
| Current Ratio | 3.41 |
| Quick Ratio | 3.21 |
| Debt / Equity | 2.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -184.99% and return on invested capital (ROIC) is -46.78%.
| Return on Equity (ROE) | -184.99% |
| Return on Assets (ROA) | -36.33% |
| Return on Invested Capital (ROIC) | -46.78% |
| Return on Capital Employed (ROCE) | -113.07% |
| Revenue Per Employee | $51,133 |
| Profits Per Employee | -$3.11M |
| Employee Count | 30 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid $39,000 in taxes.
| Income Tax | 39,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.99% in the last 52 weeks. The beta is 0.04, so LYRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -97.99% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 42.49 |
| Average Volume (20 Days) | 1,773,671 |
Short Selling Information
The latest short interest is 2.41 million, so 3.66% of the outstanding shares have been sold short.
| Short Interest | 2.41M |
| Short Previous Month | 2.40M |
| Short % of Shares Out | 3.66% |
| Short % of Float | 5.17% |
| Short Ratio (days to cover) | 2.74 |
Income Statement
In the last 12 months, LYRA had revenue of $1.53 million and -$93.44 million in losses. Loss per share was -$1.43.
| Revenue | 1.53M |
| Gross Profit | -42.23M |
| Operating Income | -60.73M |
| Pretax Income | -68.82M |
| Net Income | -93.44M |
| EBITDA | -60.26M |
| EBIT | -60.73M |
| Loss Per Share | -$1.43 |
Full Income StatementBalance Sheet
The company has $40.58 million in cash and $34.38 million in debt, giving a net cash position of $6.20 million or $0.09 per share.
| Cash & Cash Equivalents | 40.58M |
| Total Debt | 34.38M |
| Net Cash | 6.20M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 11.59M |
| Book Value Per Share | 0.18 |
| Working Capital | 30.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.01 million and capital expenditures -$2.34 million, giving a free cash flow of -$72.35 million.
| Operating Cash Flow | -70.01M |
| Capital Expenditures | -2.34M |
| Free Cash Flow | -72.35M |
| FCF Per Share | -$1.10 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -3,959.13% |
| Pretax Margin | -6,088.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.74% |
| Shareholder Yield | -30.74% |
| Earnings Yield | -1,431.14% |
| FCF Yield | -1,108.16% |
Analyst Forecast
The average price target for LYRA is $1.25, which is 1,090.48% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.25 |
| Price Target Difference | 1,090.48% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 135.52% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LYRA has an Altman Z-Score of -9.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.77 |
| Piotroski F-Score | 3 |